0001209191-16-130925.txt : 20160705
0001209191-16-130925.hdr.sgml : 20160705
20160705161144
ACCESSION NUMBER: 0001209191-16-130925
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160701
FILED AS OF DATE: 20160705
DATE AS OF CHANGE: 20160705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdollahian Neil
CENTRAL INDEX KEY: 0001678223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 161750569
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-07-01
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001678223
Abdollahian Neil
6310 NANCY RIDGE DR
SUITE 101
SAN DIEGO
CA
92121
0
1
0
0
Chief Business Officer
Stock Option (right to buy)
10.45
2016-07-01
4
A
0
100000
0.00
A
2026-06-30
Common Stock
100000
100000
D
25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of July 1, 2016; 1/48th of the shares subject to the option shall vest monthly thereafter, such that all shares will be vested on July 1, 2020.
/s/ Marc Wilson, Attorney-in-Fact
2016-07-05